Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services primarily for the research and clinical diagnostic markets. The company operates through two main segments: Protein Sciences, which contributes approximately 60% of revenue, and Diagnostics and Genomics, accounting for about 40%. Key products include biological reagents, diagnostic assays, and analytical tools. Factors supporting the company's endurance include a diverse product portfolio and strong demand in life sciences, while potential limitations include competition and reliance on research funding.
—
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services primarily for the research and clinical diagnostic markets. The company operates through two main segments: Protein Sciences, which contributes approximately 60% of revenue, and Diagnostics and Genomics, accounting for about 40%. Key products include biological reagents, diagnostic assays, and analytical tools. Factors supporting the company's endurance include a diverse product portfolio and strong demand in life sciences, while potential limitations include competition and reliance on research funding.
—
Daily adjusted close
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services primarily for the research and clinical diagnostic markets. The company operates through two main segments: Protein Sciences, which contributes approximately 60% of revenue, and Diagnostics and Genomics, accounting for about 40%. Key products include biological reagents, diagnostic assays, and analytical tools. Factors supporting the company's endurance include a diverse product portfolio and strong demand in life sciences, while potential limitations include competition and reliance on research funding.